Dr. Reddy's Laboratories Limited (RDY) Q3 2010 Earnings Results

Dr. Reddy's Laboratories Misses on EPS — Stock Down 6.46%

Dr. Reddy's Laboratories reported a significant loss in EPS, which was much worse than expected. The stock reacted negatively, dropping 6.46% following the announcement. Investors may be concerned about the company's financial health given the substantial EPS miss.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.70	N/A	-289.19%

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Dr. Reddy's Laboratories Misses on EPS — Stock Down 6.46%

Key numbers

Management commentary

Dr. Reddy's Laboratories Limited

More earnings this week

Dr. Reddy's Laboratories Misses on EPS — Stock Down 6.46%

Key numbers

Management commentary